Table 1.
Agent | MIC or MFCa | MIC (μg/ml) for the indicated isolate at the indicated time |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ATCC 201110 |
Clinical isolate 1 |
Clinical isolate 2 |
Clinical isolate 3 |
Clinical isolate 4 |
|||||||
24 h | 48 h | 24 h | 48 h | 24 h | 48 h | 24 h | 48 h | 24 h | 48 h | ||
Fluconazole | MIC-2 | 0.5 | 4 | 0.5 | 0.5 | 4 | 16 | 0.5 | 2 | 4 | 4 |
MIC-0 | 4 | 4 | 4 | 4 | 16 | 32 | 16 | 16 | 32 | 32 | |
MFC | 8 | 32 | 16 | 32 | 32 | 64 | 16 | 16 | 64 | 64 | |
Itraconazole | MIC-2 | 0.25 | 0.5 | 0.12 | 0.12 | 0.06 | 0.25 | 1 | 1 | 0.12 | 0.12 |
MIC-0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | |
MFC | 2 | 2 | 8 | >8 | 2 | 2 | 2 | 2 | 4 | 4 | |
Voriconazole | MIC-2 | ≤0.015 | 0.06 | ≤0.015 | 0.03 | 0.06 | 0.25 | 0.12 | 0.25 | 0.03 | 0.03 |
MIC-0 | 0.12 | 0.12 | 0.06 | 0.12 | 0.25 | 0.5 | 0.25 | 0.5 | 0.5 | 0.5 | |
MFC | 0.25 | 0.25 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | |
Posaconazole | MIC-2 | 0.12 | 0.12 | 0.06 | 0.06 | ≤0.015 | 0.5 | 0.06 | 0.12 | 0.25 | 0.5 |
MIC-0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | |
MFC | 2 | 2 | 2 | 8 | 2 | 2 | 2 | 2 | 2 | 2 | |
Isavuconazole | MIC-2 | ≤0.015 | ≤0.015 | ≤0.015 | 0.03 | ≤0.015 | 0.12 | 0.12 | 0.12 | 0.25 | 0.5 |
MIC-0 | 0.5 | 0.5 | 0.25 | 0.5 | 0.25 | 0.5 | 1 | 1 | 1 | 1 | |
MFC | 8 | 8 | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 2 |
MIC-2, reading endpoint which provides ∼50% reduction in turbidity compared to the growth control well; MIC-0, reading endpoint at concentration which provides complete inhibition of growth. MFC, minimum fungicidal concentration.